Training Areas
Education
B.Sc., Hebrew University
ChemistryM.Sc., Hebrew University
BiophysicsPh.D., Hebrew University
Biophysics
Awards
1996 -
Research to Prevent Blindness Senior Scientific Investigators Award
1985 - 1990
Jules and Doris Stein Research to Prevent Blindness Professorship
1978 - 1979
Research Fellowship
Welcome Foundation of the United Kingdom
Research
Recent Activities at Meetings and Congresses
Invited speaker. ARVO Western Research Conference on "Regenerative Ocular Biology." Laguna Beach. September 25-28th , 2005.Session Leader. Symposium of "Basic Perspectives On Ocular Surface Stem Cells." International Congress of Eye Research. Buenos Aires, Argentina. October 29-November 3rd, 2006.
Invited speaker. ARVO Western Research Conference on "Regenerative Ocular Biology." Laguna Beach. September 25-28th , 2005.
Session Leader. Symposium of "Basic Perspectives On Ocular Surface Stem Cells." International Congress of Eye Research. Buenos Aires, Argentina. October 29-November 3rd, 2006.
Publications
Matic M, Petrov IN, Chen S, Wang C, Dimitrijevich SD, Wolosin J. Stem cells of the corneal epithelium lack connexins and metabolite transfer capacity. Differentiation 1997; 61: 251-260.
Wolosin J, Candia OA, Peterson-Yantorno K, Civan MM, Shi XP. Effect of heptanol on the short circuit currents of cornea and ciliary body demonstrates rate limiting role of heterocellular gap junctions in active ciliary body transport. Exp Eye Res 1997; 64: 945-952.
Matic M, Stegman Z, Buku A, Wolosin J. Differentiation dependent expression of a2,3msialyltransferase in rabbit corneal epithelium. Invest Ophthalmol Vis Sci 1998; 39: 905-912.
Schutte M, Chen S, Wolosin J. Cx50, a gap junction protein of microglia in retinal and visual pathways. Exp Eye Res 1998; 66: 605-613.
Wolosin J, Xiong X, Schutte M, Stegman Z, Tieng A. Stem Cells and Differentiation Stages in the Limbo-Corneal Epithelium. Prog Retin Eye Res 2001; 19: 223-255.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Wolosin did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Basic Sciences Building Floor 22 Room 81
10 East 101st Street
New York, NY 10029
Annenberg Building Floor 22 Room 76
1468 Madison Avenue
New York, NY 10029
1468 Madison Avenue
22nd Floor, Room 76
New York, NY 10029
